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A phosphoramidate substrate analog is a competitive inhibitor
of the Tetrahymena group I ribozyme
Raven L Hanna 1, Sergei M Gryaznov 3 and Jennifer A Doudna 1;2
Background: Phosphoramidate oligonucleotide analogs containing N3P^P5P
linkages share many structural properties with natural nucleic acids and can be
recognized by some RNA-binding proteins. Therefore, if the N^P bond is resistant
to nucleolytic cleavage, these analogs may be effective substrate analog
inhibitors of certain enzymes that hydrolyze RNA. We have explored the ability of
the Tetrahymena group I intron ribozyme to bind and cleave DNA and RNA
phosphoramidate analogs.
Results: The Tetrahymena group I ribozyme ef¢ciently binds to phosphoramidate
oligonucleotides but is unable to cleave the N3P^P5P bond. Although it adopts an
A-form helical structure, the deoxyribo-phosphoramidate analog, like DNA, does
not dock ef¢ciently into the ribozyme catalytic core. In contrast, the ribo-
phosphoramidate analog docks similarly to the native RNA substrate, and
behaves as a competitive inhibitor of the group I intron 5P splicing reaction.
Conclusions: Ribo-N3P^P5P phosphoramidate oligonucleotides are useful tools
for structural and functional studies of ribozymes as well as protein^RNA
interactions.
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Introduction
Group I introns are catalytic RNAs capable of self-splicing
from precursor transcripts. Hundreds of examples of group
I introns, characterized by common secondary structural
elements, have been identi¢ed in a variety of species
[1,2]. The Tetrahymena thermophila intervening sequence
of nuclear pre-rRNA, the ¢rst self-splicing intron discov-
ered [3], has been characterized extensively and is used as
a model system [4]. The secondary structure of the wild
type Tetrahymena group I intron is shown in Figure 1a. The
splicing reaction performed by the intron occurs through a
two-step trans-esteri¢cation mechanism (Figure 1b). In the
¢rst step, the intron binds an exogenous guanosine nucle-
otide (Ge), positioning its 3P-hydroxyl for nucleophilic at-
tack on the phosphate at the 5P splice site. Following
strand scission at the 5P exon^intron junction, the 3P-hy-
droxyl group of the cleaved 5P exon attacks the phosphate
at the 3P splice site to produce ligated exons and a free
intron, which retains catalytic activity [5^7]. Several specif-
ically positioned magnesium ions are essential for RNA
structure stability and transition state stabilization [8^10].
Group I introns are often studied as multiple turnover
enzymes by separating the 5P exon from the intron and
deleting the 3P exon [11]. These engineered constructs
(L-18-ScaI, L-21-ScaI) cleave a short oligonucleotide sub-
strate using an exogenous guanosine (Ge), analogous to the
¢rst step of the native reaction (Figure 1c). The ribozyme
can also be engineered to perform the reverse of the sec-
ond step of the reaction. In these ribozyme constructs (L-
18-gG, L-21-gG), the terminal G (Gg) serves as the at-
tacking nucleophile to cleave short oligonucleotide sub-
strates in trans (Figure 1d), causing the intron to become
covalently attached to the reaction product.
The Tetrahymena group I ribozyme binds a trans-substrate
in two steps: duplex formation and docking. Duplex for-
mation is accomplished through Watson^Crick base pairing
of the substrate to the internal guide sequence (IGS). This
duplex, termed P1, then docks into the reaction core
through a number of tertiary interactions involving hydro-
gen bonds to 2P-hydroxyl groups of the substrate backbone
[12]. Deoxyribose-containing substrates, which lack the 2P-
hydroxyl groups, are unable to ef¢ciently dock into the
reaction core and hence are much less reactive than
RNA substrates [13,14]. In addition to tertiary interactions
between the substrate and the ribozyme core, binding of
metal ions and the guanosine co-substrate contribute to
substrate docking ef¢ciency [15].
Available crystal structures of parts of the Tetrahymena
group I intron [16,17] are not complete or detailed enough
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Structural studies to elucidate the mechanism have been
dif¢cult because no known substrate analog could com-
pletely inhibit the cleavage reaction while leaving the re-
action core structurally intact. DNA oligonucleotides or
RNA oligonucleotide analogs containing 2P-deoxy or phos-
phorothioate substitutions decrease the reaction rate
[13,18], but this is more likely due to improper substrate
docking rather than direct inhibition of the chemical step.
Detailed structural analysis of the group I ribozyme reac-
tion mechanism will be aided by non-cleavable substrate
analogs that more closely mimic the properties of the RNA
substrate.
The increasing interest in using nucleic acid analogs for
clinical purposes has led to development of chemically
stable analogs of DNA and RNA. The N3P^P5P phosphor-
amidate nucleic acid analogs, where each 3P-oxygen is re-
placed by a 3P-amino group (Figure 2), are promising anti-
sense agents [19^22] as well as potential tools for basic
research in the ¢eld of RNA structure and chemistry.
Although protonation of the nitrogen in acidic conditions
causes degradation, these analogs are stable at physiologi-
cal pH [23]. Phosphoramidate DNA oligonucleotides [24]
form RNA-like A-form duplexes which are more thermally
stable than RNA or DNA helices of the same sequence
[25,26]. They also form speci¢c and stable heteroduplexes
with natural nucleic acids, including triple helices [27], and
they show signi¢cant nuclease resistance [28]. Further-
more, helices composed of the phosphoramidate DNA ana-
log can function as RNA mimics which can be speci¢cally
recognized by RNA-binding proteins, such as HIV Rev
and Tat, presumably due to their preference for RNA-
like helical geometry [29,30]. The phosphoramidate
DNA analog has also been used to prevent substrate bind-
ing to the Pneumocystis carinii group I intron [31,32]. More
recently, the synthesis of phosphoramidates containing 2P-
hydroxyl groups was reported [23,33]. These analogs can
also form heteroduplexes and triplexes with RNA and
DNA which are signi¢cantly more stable than their phos-
phodiester counterparts.
Based on their structural and chemical properties, the
phosphoramidate-containing oligonucleotide analogs are
good candidates for substrate analog inhibitors to the group
I intron ribozyme. We show here that a phosphoramidate
RNA analog is a competitive inhibitor of the Tetrahymena
Figure 1. The T. thermophila group I intron. (a) Secondary structure diagram of the Tetrahymena group I intron. Magenta arrows mark the
3P and 5P splice sites. The four ribozyme constructs used in these experiments are combinations of the length variants marked in blue. The
additional 5P nucleotides present in the cis-acting wild type molecule are shown in gray. Sequences are identical between the variants,
except the A denoted by an asterisk in the P1 stem, which is an A in the wild type intron and the L-18 constructs, but a U in the L-21
constructs. The cyan nucleotides marked by asterisks have been changed from uracils, to ensure ef¢cient transcription with bacteriophage
T7 RNA polymerase. A30, highlighted in orange, becomes accessible to DMS upon substrate docking. Schematic diagrams of (b) the cis-
reaction of the natural group I intron, (c) the multi-turnover trans-reaction of an engineered construct (L-21-ScaI), and (d) the single
turnover trans-reaction of an engineered construct (L-18-gG) are shown. The £anking exons are colored dark blue. Mapped on to the gray
body of the group I intron is the P1 substrate helix in black. Ge is the exogenous guanosine co-factor and Gg is the terminal guanosine of
the intron. Magenta arrows are drawn between the nucleophile and labile bond for each step of the reactions.
6
Figure 2. The chemical structures of the substrates and analogs. The sugars of two representative nucleotides from the four 9-mer
oligonucleotides used in this study have been drawn, and the chemical differences are highlighted.
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group I intron ribozyme. This substrate mimic binds to the
ribozyme active site like the native substrate but is com-
pletely unreactive. Unlike other group I intron substrate
analogs, the phosphoramidate oligonucleotide blocks RNA-
catalyzed transesteri¢cation chemically rather than by per-
turbing active site structure.
Results and discussion
Four 9 nucleotide (9-mer) substrates (Figure 2) isosequen-
tial to the 5P half of the P1 substrate helix (5P-CUCU-
CUGCC) were used to compare the properties of the 2P-
deoxy phosphoramidate (d-NP) and the 2P-hydroxyl phos-
phoramidate (r-NP) analogs to DNA and RNA substrates.
To determine whether the N^P bond confers increased
stability against enzymatic activity, the various substrates
were subjected to alkaline hydrolysis and enzymatic cleav-
age agents (Figure 3). Like RNA, the r-NP analog is sen-
sitive to alkaline hydrolysis, demonstrating that, despite
the nitrogen substitution, the 2P-hydroxyl is able to attack
the adjacent phosphate and cleave the P^O5P bond, creat-
ing a cyclic phosphate product. Similarly, RNase A, which
cleaves RNA via a cyclic phosphate intermediate, recog-
nizes and cleaves the r-NP backbone. Micrococcal nuclease
(S7) catalyzes hydrolysis of the P^O5P bond of DNA and
RNA through a nucleophilic in-line attack [34] and is able
to cleave both d-NP and r-NP. However, nucleases P1 and
S1, which both target the O3P^P bond, are not able to
cleave the N^P oligonucleotides. Despite the difference
in bond speci¢city, the active site of nuclease P1 has a
similar arrangement to nuclease S7 [35]. This suggests
that speci¢c properties of the N^P bond render it resistant
to nucleolytic cleavage by the nucleases P1 and S1 yet still
allow adjacent bonds to maintain their usual chemical func-
tionalities, such as susceptibility to nuclease S7 cleavage.
The L-18-ScaI Tetrahymena ribozyme, which catalyzes the
nucleolytic cleavage of the O3P^P bond, was tested for its
ability to cleave the d-NP and r-NP analog molecules using
standard reaction conditions (Figure 4). No cleavage of
either of the N^P analog oligonucleotides occurred after
even 10 days of incubation, which corresponds to at least
a 10 000-fold decrease in reaction rate for both of the ana-
logs.
The lack of N^P analog cleavage by the catalytic RNA
could be due to a disruption of any part of the substrate
binding and cleavage pathway for the ribozyme. Base pair-
ing to the IGS, docking of the resulting duplex into the
ribozyme active site, and/or the chemical step of the reac-
tion could be disrupted by the presence of the N^P bond.
Apparent dissociation constant (Kappd ) values of the ribo-
zyme^substrate complexes were measured to determine
whether the phosphoramidate bond disrupts complex for-
mation (Table 1). For the Tetrahymena group I ribozyme,
the product RNA binds more tightly to the ribozyme than
the substrate RNA [36]. For comparison, the apparent Kd
of the 6-mer product RNA and the L-18-ScaI ribozyme
Figure 3. Nuclease cleavage of phosphoramidate analogs. (a) Cleavage sites of the nucleases used are marked in blue. The 2P-oxygen,
highlighted in red, is exchanged for a nitrogen in the phosphoramidate analogs. (b) The ability for each oligonucleotide to be cleaved by
the various chemical and enzymatic mechanisms is denoted with a plus or minus. aSee [48,49].
Table 1
Stability of the substrates bound to the ribozymes:
Kd (nM) values.
L-18-gG L-18-ScaI L-21-gG L-21-ScaI
R6 n.d.a 0.1 þ 0.05 n.d. 2 þ 0.5
DNA s 1000 s1000 s 1000 s 1000
RNA n.d. 2.7 þ 0.2 n.d. 2.9 þ 0.8
d-NP 11 þ 1 16 þ 3 45 þ 5 90 þ 10
r-NP 2.6 þ 0.2 6.5 þ 0.5 4.6 þ 0.4 1.4 þ 0.3
Equilibrium dissociation binding constants measured from gel shift
experiments. Kappd values are in nM. This assay was not sensitive
above 1000 or below 0.1 nM.
aBinding constants for the RNA 9-mer substrate and the RNA
6-mer product with the ribozymes containing the 3P terminal G
were not determined (n.d.) due to cleavage. Binding constants be-
tween RNA substrate and the ribozymes truncated at the ScaI
site are not at equilibrium, since the oligonucleotide is susceptible
to ribozyme-directed hydrolysis.
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was found to be 0.1 nM (313.6 kcal/mol), which is similar
to values measured previously under similar conditions
[12,37,38]. The low af¢nity of DNA substrates for the ri-
bozyme has been shown to result from poor docking due to
the lack of tertiary interactions mediated by substrate 2P-
hydroxyl groups and the adoption of a different helical
conformation [18]. The d-NP analog binds the ribozyme
quite ef¢ciently, despite the inability to form tertiary inter-
actions, which is likely due to the increased propensity to
form an RNA-like helical structure. The values for r-NP
oligonucleotide binding are similar to those for the RNA
substrate, suggesting that there is no signi¢cant disruption
of duplex formation. As with the d-NP analog, the de-
crease in P1 helix length between the L-18 and L-21 con-
structs (Figure 1d) causes a 0.8 kcal/mol destabilization in
the r-NP analog bound to the ribozymes ending at the ScaI
site. The values for r-NP analogs bound to ribozymes con-
taining the terminal guanosine residue, which has a coop-
erative affect on substrate docking when bound in the G-
binding site, show the opposite trend, having a small in-
crease in complex stability for the shorter P1 helix when
Gg is present. Therefore, these observed K
app
d values re-
£ect the opposing forces of substrate binding: helix stabi-
lization is maximized by a longer helix, while substrate
docking is more ef¢cient with a shorter helix.
While N^P oligonucleotides are capable of ef¢cient bind-
ing to the Tetrahymena ribozyme, the observed lack of
cleavage might be caused by improper docking rather
than inhibition of the chemical step. To test this possibil-
ity, dimethyl sulfate (DMS), which methylates the N1 of A
residues, was used to test substrate docking into the ribo-
zyme core. The adenosine at position 30 (A30, Figure 1d),
which resides at the base of P1 in the intron, is readily
modi¢ed by DMS when the ribozyme is bound to a
docked RNA substrate or cleavage product, but remains
unmodi¢ed when bound to an oligo incapable of forming
tertiary interactions [39]. Samples of L-18-gG RNA (Fig-
ure 1c,d) complexed with DNA, RNA, or N^P analog oli-
gonucleotides were treated with DMS and the sites of
DMS modi¢cation were identi¢ed by reverse transcription
(Figure 5a). There is no modi¢cation of A30 in the absence
of magnesium, a condition under which the ribozyme is
unfolded, or in a folded ribozyme without substrate. Ribo-
zymes bound to the DNA substrate, which is unable to
ef¢ciently dock into the active site, show a low degree of
modi¢cation at A30, while the ribozymes bound to the
RNA substrate have strong methylation at A30. The com-
plex with the d-NP oligonucleotide, as with DNA, shows
little modi¢cation and therefore is apparently undocked,
while the strong modi¢cation of A30 in the r-NP complex
suggests ef¢cient docking, similar to the RNA substrate.
To further evaluate the structural properties of the ribo-
zyme^substrate complexes, labeled substrates pre-bound
to the L-18-ScaI ribozyme were subjected to native poly-
Figure 4. Fraction substrate cleaved vs. time. The four substrates
(DNA, blue squares; RNA, red circles; d-NP, green triangles;
r-NP, orange diamonds) were incubated with L-18-ScaI ribozyme.
Percent substrate cleaved was plotted for ¢ve time points:
1.5 min, 1 h, 1 day, 5 days, and 10 days. Parallel reactions
without ribozyme showed no cleavage, except for minor
background hydrolysis of the RNA substrate (less than 5%
cleaved in 10 days).
Figure 5. Docking of the substrates into the ribozyme core.
(a) DMS chemical modi¢cation of L-18-ScaI ribozyme with the
substrates. Ribozyme molecules modi¢ed with DMS while
complexed to various substrates were reverse-transcribed using a
5P end-labeled DNA primer. A30 is protected when the substrate
is not docked and is deprotected when the substrate is docked.
(b) Non-denaturing (native) gel of 5P end-labeled substrate
complexed to the L-18-ScaI ribozyme. The RNA cleavage 6-mer
oligonucleotide (R6) and the RNA substrate serve as markers for
properly docked complexes, while an RNA 6-mer oligonucleotide
with a single 2P-O-methyl substitution (Rm6) and the DNA are
undocked.
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acrylamide gel electrophoresis, in which the overall shape,
size, and charge of molecules in their folded state deter-
mine the rate of migration (Figure 5b). The docked RNA
substrate/ribozyme and product/ribozyme complexes have
a slightly increased mobility compared to the undocked
complexes, such as those bound to DNA or an RNA 6-
mer oligonucleotide containing a 2P-O-methyl modi¢cation
at the 33 position [40]. A gel shift using the L-21-ScaI
ribozyme, which has a shorter P1 duplex, is less pro-
nounced (data not shown), supporting the theory that the
lower migration rate of undocked complexes is caused by
exposure of the P1 helix. Ribozymes bound to r-NP mi-
grate at the same rate as the docked complexes, RNA 9-
mer and 6-mer. Those bound to d-NP migrate more
slowly, as do those complexed to DNA and 33-O-methyl-
ated RNA oligonucleotides, which do not dock ef¢ciently
[12,40]. These data suggest that the r-NP analog docks
properly into the reaction core, while the d-NP analog
does not.
The similarity in behavior of ribozymes complexed with r-
NP oligonucleotides to those complexed with the RNA
substrate indicates that the substrate analog probably in-
hibits the chemical step of the reaction and is a compet-
itive inhibitor of the ribozyme reaction with native RNA
substrate. A competitive inhibitor slows an enzymatic re-
action by reversibly binding to the substrate binding site,
thereby excluding the substrate. The hallmarks of compet-
itive inhibition are a constant maximum velocity (Vmax) and
an increase in the apparent Michaelis constant (KappM ) when
the inhibitor is present [41]. To test whether the r-NP
substrate analog exhibits these properties, the L-21-ScaI
(Figure 1b,d) ribozyme was used under multiple turnover
conditions, containing excess RNA substrate and guano-
sine co-factor. Using these experimental conditions, the
value of kcat (turnover number) is 0.08 min31 and kcat/KM
(speci¢city constant) is 4.5U107 M31 min31, which are
similar to previously measured values [11,37]. The initial
velocity of this reaction was measured at four inhibitor
concentrations (0, 3, 9, and 15 nM), with each of six sub-
strate concentrations (0.75, 1, 1.5, 2, 5, and 25 nM). A
Lineweaver^Burk plot of these data (Figure 6) shows
that Vmax remains unaltered upon the addition of inhibitor,
while the slope, KappM /Vmax, increases as the inhibitor con-
centration increases, demonstrating competitive inhibi-
tion.
The r-NP substrate analog acts as a competitive inhibitor
by binding speci¢cally and tightly to the ribozyme and
docking into the reaction core. Why does it resist cleavage
by the ribozyme? Previous work has shown that an essen-
tial divalent metal ion directly coordinates the 3P-oxygen of
the substrate at the cleavage site (Figure 7). Nitrogen,
which replaces this oxygen in the analogs, does not coor-
dinate magnesium as readily [42]. If inef¢cient metal ion
coordination is responsible for the lack of ribozyme-medi-
ated cleavage of the N^P linkage, adding ‘soft’ metal ions,
which are able to coordinate nitrogen more ef¢ciently, may
rescue the activity. Three ‘soft’ metal ions, manganese,
zinc and cadmium, were individually added to the cleavage
Figure 7. Tetrahymena group I intron transition state diagram.
The substrate strand is shown in blue and the 2P-oxygen, which is
exchanged for a nitrogen in the phosphoramidate analogs, is red.
Three magnesium ions and a nucleotide triad help to stabilize the
transition state [8^10,50].
Figure 6. Reaction inhibition by the N^P RNA analog.
Lineweaver^Burk plot of 1/[S] vs. 1/V at various inhibitor
concentrations ([I]).
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assay, and the reactions were followed for 10 days (Figure
8). Neither manganese nor cadmium affect the rate of the
reaction, but there is a slight decrease in the rate of RNA
cleavage and an increase in the rate of DNA cleavage in
the presence of zinc. This may be due to a zinc-induced
distortion of the geometry of the active site, which could
lower the energy barrier of the substrate helix docking for
DNA, but may disrupt RNA-binding. The d-NP and r-NP
analogs do not show cleavage in the presence of any of the
‘soft’ metal ions. These observations suggest that inef¢-
cient magnesium ion coordination is not the key inhibitory
factor, but do not rule out this possibility completely. An-
other possibility is that slight geometric differences be-
tween RNA and r-NP in the docked core could account
for the lack of reactivity. This seems unlikely since the
core is £exible enough that even DNA, which is unable
to form critical tertiary interactions, is slowly hydrolyzed. It
is more likely that the ribozyme is chemically unable to
hydrolyze the N3P^P5P bond.
The group I intron has been shown to utilize a bimolecular
nucleophilic substitution (SN2) reaction mechanism [6,43].
The rate of an SN2 reaction depends upon the solvation of
the components, the steric accessibility of the electrophile,
the nucleophilicity of the attacking group, and the nucle-
ofugality of the leaving group. In the Tetrahymena ribozyme
system, the effect of solvation can be excluded since the
reaction takes place within a solvent inaccessible active
site. The hydrogen on the 3P-amino group is the only steric
addition and is not likely to affect the positioning of the
phosphate oxygens in a manner that would exclude the
attack of the nucleophile. The nucleophilicity of the at-
tacking oxygen becomes important when considering the
electrophilicity of the leaving group. In the pentavalent
transition state structure (Figure 7), charge from the nucle-
ophile is transferred to the leaving group, so that each has a
partial negative charge [44]. The better the leaving group,
compared with the nucleophile, the faster the reaction will
progress. Both hydroxyls and amines are considered to be
poor leaving groups because their basicity precludes the
ability to readily support the extra negative charge. To
improve the 3P-oxygen as a leaving group, the ribozyme
positions cations which directly, and through a hydrogen
bonding network, help support distribution of the negative
charge. It is possible that this network is disrupted when
oxygen is substituted by nitrogen, either due to disrupted
metal ion coordination as discussed above or as a conse-
quence of having an extra proton in the catalytic site. Even
if the hydrogen bonding network is able to form, negative
charge may not transfer to the amino leaving group in the
transition state, because it is a poorer leaving group relative
to the hydroxyl nucleophile. Additionally, the proposed
interaction between the lone electron pair on the nitrogen
and the c* antibonding orbital of the phosphate [30] would
increase the energy of the N^P bond, perhaps rendering it
an even poorer leaving group.
Although the reduced nucleofugality of the amine leaving
group is likely to cause a decrease in reaction rate, it may
not fully explain the observed s 10 000-fold decrease. An
increased stability of the electrophile may discourage nu-
cleophilic attack. A pseudo ¢ve-membered ring caused by
the formation of a hydrogen bond between the amine and
the 2P-oxygen, sharing either hydrogen, would facilitate the
Figure 8. Plots of fraction substrate cleaved vs. time in the
presence of soft metal ions. The four substrates (DNA, blue
squares; RNA, red circles; d-NP, green triangles; r-NP, orange
diamonds) were incubated with L-18-ScaI ribozyme with 2 mM
(a) magnesium chloride, (b) zinc chloride, or (c) cadmium
chloride. Fraction substrate cleaved was plotted for the ¢ve time
points taken: 1.5 min, 1 h, 1 day, 5 days, and 10 days. Parallel
reactions without ribozyme showed no cleavage.
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formation of a double bond between the nitrogen and
phosphate. Such an arrangement would cause the phospho-
rous atom to be less electrophilic, and, therefore, less sus-
ceptible to nucleophilic attack. The steric and electronic
£exibility of the nitrogen could allow the double bond to
occur, whereas an oxygen atom would prefer to remain in
an sp3 orbital state.
The inhibitory properties of the phosphoramidate oligonu-
cleotide analogs are not limited to the Tetrahymena ribo-
zyme system. The 200 nucleotide Azoarcus sp. bh72 group
I intron is also able to bind the d-NP analog without cata-
lyzing cleavage (data not shown). Therefore, the phosphor-
amidate analogs may be useful as general inhibitors for all
group I introns. Furthermore, these properties may also
hold for other RNA or protein enzymes which act on
RNA substrates through nucleophilic attack and cleavage
of the O3P^P5P bond.
Signi¢cance
The N3P^P5P phosphoramidate RNA analog is the ¢rst
group I ribozyme inhibitor identi¢ed to mimic native
RNA substrate binding interactions, while being com-
pletely inert to cleavage. This substrate analog inhibitor
binds tightly to RNA, forming helices more thermally sta-
ble than those of analogous RNA^RNA duplexes, and can
form tertiary interactions with RNA. Some protein-based
enzymes recognize the analog as RNA and cleave the P^
5PO bond. Yet, neither the nucleases tested nor the Tetra-
hymena ribozyme were able to cleave the 3PN^P bond.
Displaying many properties of RNA, this inhibitor may
prove to be a useful tool for studying the structure and
chemistry of enzymes that act on RNA.
The cleavage properties of the r-NP analog lead to the
prediction that the small ribozymes which use a cyclic
phosphate intermediate, such as HDV, VS, and hammer-
head, would be able to cleave phosphoramidate oligonu-
cleotides. However, it is likely that r-NP linkage would be
an effective inhibitor for the group II intron, the spliceo-
some, and RNase P, which use a similar mechanism to the
group I intron.
Furthermore, the recognition of this nucleic acid analog by
proteins and RNA enzymes, in addition to the analog’s
increased stability in vivo, may have consequences for its
adaptation for other uses, such as in vitro diagnostics or
gene therapy.
Materials and methods
Preparation of ribozyme RNA
Genes encoding the RNA constructs utilized in this study were ampli¢ed
from a plasmid containing the wild type T. thermophila group I intron
sequence using PCR and cloned into pUC19 vectors behind the bacter-
iophage T7 RNA polymerase promoter sequence [45]. Plasmids were
linearized for run-off transcription with either ScaI or BamHI restriction
endonuclease. RNAs were transcribed in vitro using T7 RNA polymer-
ase in transcription buffer (25 mM Tris^Cl, pH 8.0, 25 mM MgCl2, 4 mM
dithiothreitol, 0.01% (w/v) Triton X-100, 2 mM spermidine, 4 mM each
NTP, 0.06 Wg/Wl linearized plasmid, 2 Wg inorganic pyrophosphatase)
and incubated at 37³C for 3^4 h. The transcripts from the plasmids
digested with BamHI carry out site-speci¢c self-hydrolysis at the 3P
splice site during the incubation. The transcripts were subsequently
puri¢ed on a stacked semi-denaturing gel (4 and 7% polyacrylamide,
1UTBE, 1 M urea). The bands were visualized by UV shadowing, ex-
cised, diced, frozen at 380³C for 10 min, and allowed to elute in water
overnight at room temperature. The elutions were then ¢ltered through a
0.2 micron ¢lter, concentrated and de-salted, and stored at room tem-
perature in water. Preceding each experiment, 14 nM ribozyme was
annealed by heating in annealing buffer (50 mM Tris^Cl, pH 7.5, 10
mM MgCl2, 10 mM NaCl, 0.1 M EDTA) at 50³C for 10^15 min, then
allowed to slow cool to 25³C.
Preparation of substrates
The synthetic DNA 9-mer substrate (Keck Synthesis Lab, Yale Univer-
sity) was extracted with 10 volumes of n-butanol, precipitated with 2.5
volumes of ethanol and stored in water at 320³C. The RNA 9-mer
substrate and 6-mer product (Dharmacon Research Inc.) were depro-
tected as described [46] and subsequently puri¢ed by high performance
liquid chromatography using MonoQ HR and C18 reverse phase col-
umns. The N^P analogs were synthesized and puri¢ed as described
previously [33]. Substrates were 5P end-labeled with 32P using T4 poly-
nucleotide kinase, puri¢ed through denaturing gel electrophoresis on a
20% polyacrylamide gel, and ethanol-precipitated.
Ribozyme cleavage assay
Annealed L-18-ScaI ribozyme was incubated at a concentration of 50
nM in annealing buffer, 2 mM GTP, and 0.01 mg/ml tRNA at 25³C.
Trace amounts of 5P end-labeled substrate were added to a ¢nal con-
centration of 1 nM to initiate reactions and overlaid with mineral oil to
prevent sample concentration due to water evaporation during the long
incubations. Aliquots at each time point were removed and quenched
with two volumes of 10UFLB+EDTA (0.5UTBE, 80% formamide, 80
mM EDTA, 0.1% bromophenol blue, 0.05% xylene cyanol) and stored
at 320³C. Reaction products were separated by electrophoresis on a
20% polyacrylamide, 1UTBE, 7 M urea gel and the fraction cleaved
was quanti¢ed using a PhosphorImager and ImageQuant software (Mo-
lecular Dynamics (MD)). Reactions with soft metals were performed
identically, with the addition of 2 mM MnCl2, ZnCl2, or CdCl2 to the
reaction buffer.
Kd binding constants
Apparent dissociation constants were measured using a native polyac-
rylamide gel electrophoresis mobility shift assay. Ribozyme was an-
nealed as stated above and diluted in annealing buffer with 0.01 mg/
ml tRNA. Concentrations of ribozyme ranging from 0.001 to 10 000 nM
were incubated with a trace amount (s 0.01 pM) of 5P end-labeled
oligonucleotide in a buffer containing annealing buffer, 0.01 mg/ml
tRNA, 4% glycerol, and 0.05% xylene cyanol. Reactions were incubated
at 25³C for 22^26 h, followed by separation of bound and unbound
oligonucleotides by electrophoresis through an 8% polyacrylamide gel
containing 10 mM Tris^HEPES, pH 7.5, 0.1 mM EDTA (1UTHE) and 10
mM MgCl2, at 25³C. The ratio of bound to unbound substrates was
quanti¢ed using a PhosphorImager (MD) and ¢t to the equation:
a= (([E]0*a)/([E]0+Kd))+b, where a is fraction bound, [E]0 is the initial
concentration of enzyme, and Kd is the apparent dissociation constant.
The Kd values from at least three trials were averaged for each oligo-
nucleotide^ribozyme combination.
DMS chemical probing
Reactions containing 20 nM of L-18-gG ribozyme were annealed at
50³C for 20 min in annealing buffer then slow cooled to 42³C. Sub-
strates 5P end-labeled with 32P were added at concentrations 5^10-
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fold above the Kd. Reactions were allowed to equilibrate for 20 min prior
to addition of DMS to a ¢nal concentration of 0.4%. After 7 min, the
reactions were quenched by adding 200 mM L-mercaptoethanol and 15
Wg tRNA. Reactions were precipitated twice with ethanol, then immedi-
ately reverse-transcribed using a primer extension protocol previously
described [47].
Native polyacrylamide electrophoresis
10 WM L-18-gG ribozyme was annealed with 5P end-labeled oligonucleo-
tides (1 WM RNA 9-mer, d-NP 9-mer, r-NP 9-mer, RNA 6-mer, or 33
methyl RNA 6-mer or 10 WM DNA 9-mer) in annealing buffer (see
above) and 10% glycerol at 50³C for 15 min. Reactions were cooled
to 30³C over 4 h then run on a 8% polyacrylamide, 5 mM MgCl2,
1UTHE, pH 7.5 native gel with the dimensions 15U24U0.1 cm at a
constant wattage of 10 W for 12 h.
Kinetic experiments
Multiple turnover experiments were preformed using 1 nM L-21-ScaI
ribozyme with 2 mM GTP (KGdV200 WM [15]) in 1Uannealing buffer
(see above) with 0.01 mg/ml tRNA. Reactions were initiated by adding
a solution containing RNA substrate (0.75, 1, 1.5, 2, 5, or 25 nM) and
inhibitor (0, 3, 9, or 15 nM) in 1Uannealing buffer with 0.01 mg/ml tRNA.
Reactions were incubated at room temperature and time points,
quenched in ¢ve volumes of formamide buffer with 80 mM EDTA,
were taken every 2 min out to 40 min. Up to the ¢rst 10% of the reaction
was used to ¢nd the initial velocities. Inverse substrate concentration
versus inverse initial velocities were plotted on a Lineweaver^Burk plot
and the KM and Vmax were determined using the equation [41]: 1/v =
1/Vmax+KM/Vmax*1/[S].
Alkaline hydrolysis
1 nM of 5P end-labeled substrate was incubated in 50 mM sodium
bicarbonate, pH 9.3 at 90³C for 0, 1, 5, 15, 30, 60, and 180 min.
Samples were run on a 20% acrylamide/1UTBE/7 M urea gel. Hydro-
lytic cleavage was quanti¢ed on a PhosphorImager (MD).
Nuclease cleavage
1 nM of 5P end-labeled oligonucleotides were incubated with 0.1 mg/ml
RNase A in 50 mM HEPES, pH 7.0, and 1 mM EDTA, 2 Wg/ml nuclease
P1 in 15 mM sodium acetate, pH 5.3, and 1 mM ZnCl2, 10 U nuclease
S7 in 100 mM sodium borate, pH 8.6, and 1 mM CaCl2, or 4 U nuclease
S1 in 0.6 M sodium acetate, pH 4.6, 0.1 M NaCl, and 2 mM zinc acetate
at 37³C. Aliquots were removed at time points between 30 s and 2.5 h,
samples run on a a 20% acrylamide/1UTBE/7 M urea gel, and fraction
cleaved quanti¢ed on a PhosphorImager (MD).
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